Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHCO NYSE:ARDT NASDAQ:FLGT NASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$11.60-1.1%$11.31$8.06▼$13.43$1.57B1.571.32 million shs183,961 shsARDTArdent Health$10.02+1.2%$9.26$8.07▼$15.48$1.43B0.93394,736 shs36,783 shsFLGTFulgent Genetics$15.19+0.5%$15.82$13.46▼$31.04$451.96M0.88499,196 shs182,432 shsPGNYProgyny$22.46+17.2%$17.87$16.10▼$28.75$1.76B0.911.50 million shs1.35 million shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth+2.71%-10.53%-1.76%+10.14%+42.49%ARDTArdent Health+5.25%+0.89%+9.44%+10.46%-30.29%FLGTFulgent Genetics+1.27%-0.53%-5.03%-35.54%-19.12%PGNYProgyny+2.46%+3.12%+11.66%-12.71%-18.15%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$11.60-1.1%$11.31$8.06▼$13.43$1.57B1.571.32 million shs183,961 shsARDTArdent Health$10.02+1.2%$9.26$8.07▼$15.48$1.43B0.93394,736 shs36,783 shsFLGTFulgent Genetics$15.19+0.5%$15.82$13.46▼$31.04$451.96M0.88499,196 shs182,432 shsPGNYProgyny$22.46+17.2%$17.87$16.10▼$28.75$1.76B0.911.50 million shs1.35 million shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth+2.71%-10.53%-1.76%+10.14%+42.49%ARDTArdent Health+5.25%+0.89%+9.44%+10.46%-30.29%FLGTFulgent Genetics+1.27%-0.53%-5.03%-35.54%-19.12%PGNYProgyny+2.46%+3.12%+11.66%-12.71%-18.15%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHCOAdaptHealth 2.50Moderate Buy$14.0020.72% UpsideARDTArdent Health 2.36Hold$14.2141.80% UpsideFLGTFulgent Genetics 2.20Hold$27.0077.75% UpsidePGNYProgyny 2.69Moderate Buy$27.9124.24% UpsideCurrent Analyst Ratings BreakdownLatest FLGT, AHCO, PGNY, and ARDT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026ARDTArdent Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$13.00 ➝ $13.505/6/2026AHCOAdaptHealth Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$14.00 ➝ $16.005/6/2026AHCOAdaptHealth Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$18.005/6/2026AHCOAdaptHealth UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$15.00 ➝ $14.005/5/2026FLGTFulgent Genetics Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$30.00 ➝ $15.004/20/2026AHCOAdaptHealth Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$11.004/13/2026AHCOAdaptHealth Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$13.00 ➝ $14.003/27/2026PGNYProgyny Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)3/25/2026ARDTArdent Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/20/2026PGNYProgyny BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$29.00 ➝ $23.003/11/2026PGNYProgyny Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$26.00 ➝ $19.00(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHCOAdaptHealth$3.28B0.48$4.25 per share2.73$11.14 per share1.04ARDTArdent Health$6.43B0.22$2.94 per share3.41$11.78 per share0.85FLGTFulgent Genetics$322.67M1.40N/AN/A$35.10 per share0.43PGNYProgyny$1.29B1.37$0.88 per share25.40$5.99 per share3.75Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHCOAdaptHealth-$70.79M-$0.62N/A11.601.31-2.42%2.76%0.99%N/AARDTArdent Health$135.81M$0.9510.558.02N/A2.09%14.01%4.50%N/AFLGTFulgent Genetics-$60.51M-$2.39N/AN/AN/A-23.04%-3.24%-2.97%N/APGNYProgyny$58.52M$0.6534.6217.021.084.54%11.37%7.73%N/ALatest FLGT, AHCO, PGNY, and ARDT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026PGNYProgyny$0.44$0.50+$0.06$0.29$326.47 million$328.50 million5/5/2026Q1 2026AHCOAdaptHealth$0.0125-$0.12-$0.1325-$0.12$796.63 million$819.80 million5/5/2026Q1 2026ARDTArdent Health$0.18$0.28+$0.10$0.28$1.58 billion$1.60 billion3/4/2026Q4 2025ARDTArdent Health$0.35$0.32-$0.03$0.32$1.63 billion$1.61 billion2/27/2026Q4 2025FLGTFulgent Genetics$0.02$0.16+$0.14-$0.76$85.38 million$83.34 million2/26/2026Q4 2025PGNYProgyny$0.38$0.48+$0.10$0.14$314.26 million$318.40 million2/24/2026Q4 2025AHCOAdaptHealth$0.34-$0.76-$1.10-$0.76$832.51 million$846.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAHCOAdaptHealthN/AN/AN/AN/AN/AARDTArdent HealthN/AN/AN/AN/AN/AFLGTFulgent GeneticsN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHCOAdaptHealth1.210.920.81ARDTArdent Health0.641.971.85FLGTFulgent GeneticsN/A5.316.48PGNYProgynyN/A2.732.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHCOAdaptHealth82.67%ARDTArdent HealthN/AFLGTFulgent Genetics48.06%PGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipAHCOAdaptHealth1.55%ARDTArdent Health1.90%FLGTFulgent Genetics36.18%PGNYProgyny9.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHCOAdaptHealth10,900135.92 million133.81 millionOptionableARDTArdent Health25,200143.10 million140.38 millionOptionableFLGTFulgent Genetics1,31529.75 million18.99 millionOptionablePGNYProgyny31078.33 million70.57 millionOptionableFLGT, AHCO, PGNY, and ARDT HeadlinesRecent News About These CompaniesProgyny (NASDAQ:PGNY) Shares Gap Up on Earnings Beat1 hour ago | marketbeat.comProgyny, Inc. (PGNY) Q1 2026 Earnings Call TranscriptMay 8 at 5:01 AM | seekingalpha.comProgyny: Q1 Earnings SnapshotMay 8 at 1:26 AM | chron.comThe Bull Case For Progyny (PGNY) Could Change Following Flat Q1 2026 Revenue Guidance ConcernsMay 8 at 1:26 AM | finance.yahoo.comProgyny’s (NASDAQ:PGNY) Q1 CY2026 sales beat estimates, stock soarsMay 8 at 1:26 AM | msn.comProgyny (PGNY) Q1 Earnings and Revenues Beat EstimatesMay 7 at 8:05 PM | zacks.comProgyny (NASDAQ:PGNY) Updates Q2 2026 Earnings GuidanceMay 7 at 6:30 PM | marketbeat.comProgyny (NASDAQ:PGNY) Updates FY 2026 Earnings GuidanceMay 7 at 4:42 PM | marketbeat.comProgyny, Inc. Announces First Quarter 2026 ResultsMay 7 at 4:01 PM | globenewswire.comProgyny Inc (PGNY) Q1 2026: Everything You Need To Know Ahead Of EarningsMay 6 at 11:52 PM | finance.yahoo.comProgyny (PGNY) Q1 earnings report preview: What to look forMay 6 at 11:52 PM | msn.comReviewing Selectis Health (OTCMKTS:GBCS) and Progyny (NASDAQ:PGNY)May 6 at 5:37 AM | americanbankingnews.comProgyny (PGNY) Expected to Announce Earnings on ThursdayApril 30, 2026 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires 70,021 Shares of Progyny, Inc. $PGNYApril 30, 2026 | marketbeat.comShould Value Investors Buy Progyny (PGNY) Stock?April 29, 2026 | zacks.comProgyny (PGNY) Upgraded to Buy: Here's WhyApril 28, 2026 | zacks.comPGNY or ALHC: Which Is the Better Value Stock Right Now?April 28, 2026 | zacks.comProgyny, Inc. (NASDAQ:PGNY) Receives Consensus Rating of "Moderate Buy" from AnalystsApril 24, 2026 | marketbeat.comProgyny, Inc. to Report Q1 2026 Financial Results on May 7, 2026April 23, 2026 | quiverquant.comQProgyny, Inc. Announces Details for Its First Quarter 2026 Results ReportApril 23, 2026 | globenewswire.comProgyny: Significant Non-Cash Compensation Limits Value CaseApril 22, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFLGT, AHCO, PGNY, and ARDT Company DescriptionsAdaptHealth NASDAQ:AHCO$11.60 -0.13 (-1.13%) As of 11:13 AM Eastern This is a fair market value price provided by Massive. Learn more.AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Ardent Health NYSE:ARDT$10.02 +0.12 (+1.21%) As of 11:13 AM Eastern This is a fair market value price provided by Massive. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Fulgent Genetics NASDAQ:FLGT$15.19 +0.08 (+0.53%) As of 11:13 AM Eastern This is a fair market value price provided by Massive. Learn more.Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.Progyny NASDAQ:PGNY$22.46 +3.30 (+17.24%) As of 11:13 AM Eastern This is a fair market value price provided by Massive. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Wells Fargo’s Comeback Is Real—But Not Risk-Free IonQ Just Posted a Breakout Quarter—But 1 Problem Remains SLB’s Tough Quarter Masks a Powerful Long-Term Shift Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
